Jefferies, which downgraded shares of Teleflex TFX, is providing some color on the stock.
“With pure-play status on the horizon, we believe TFX shares should garner an in-line multiple with peers given its above average FCF yield and numerous initiatives to drive incremental revenue and margin expansion,” Jefferies writes. “However, recent underperformance in the Medical segment prevents us from assigning a premium multiple.”
Teleflex closed Thursday at $59.95.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in